Genome-wide association study of prostate cancer mortality
about
Inherited susceptibility for aggressive prostate cancerOncolytic adenovirus-mediated therapy for prostate cancerLifestyle and dietary factors in the prevention of lethal prostate cancerGenetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer PhenotypesThe impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysisFactors driving inequality in prostate cancer survival: a population based study.Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.SNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressivenessNational Cancer Institute Prostate Cancer Genetics WorkshopGenetic architecture of cancer and other complex diseases: lessons learned and future directions.Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleGenetic susceptibility to bladder cancer risk and outcome.Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control studyGenome abnormalities precede prostate cancer and predict clinical relapseAssociations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Gene variants in the angiogenesis pathway and prostate cancer.Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.The role of AUTS2 in neurodevelopment and human evolution.Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Nutrigenetics and prostate cancer: 2011 and beyond.Genome-wide association study of prostate cancer-specific survival.Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.Prostate cancer susceptibility genes on 8p21-23 in a Dutch population.Genome-wide Association Study (GWAS) of Germline Copy Number Variations (CNVs) Reveal Genetic Risks of Prostate Cancer in Chinese population.
P2860
Q27001297-C2E953E2-F0A6-49D7-A44F-FE2008FD8B5BQ27004796-FB128B07-8914-4477-AA4B-DE40F68775ABQ27025735-B1E5BDB2-693D-4490-A6E7-A60846BF88D2Q30504100-44EC7F28-04E9-49EE-A915-9701FE4AA08DQ33565740-D66DDB40-0191-43F4-BCAA-157D009B63FBQ33577607-59BC8296-AF83-46E5-B974-FCE294F5F26BQ34155974-6FB1F62B-B966-4AE4-BAE0-F0F596027B02Q34469841-7435DA11-98C1-4F51-8E1B-090FE6CD4407Q34636364-F22F253A-F9D2-4B02-9DCD-6C28DE54DC06Q34672464-1D515A8D-62C0-4E7B-887D-285B4636696DQ34988026-E5C2949E-D9D8-4C89-9A6A-5ADC5261ED78Q35117258-A7B2428B-50FC-4130-BCAB-EBC9556A743BQ35144499-D952D40B-8A81-4E88-A8FD-D355356371C2Q35212792-CE923729-5AFB-4C0F-A046-B9CA3D087D27Q35718345-CD04676E-4BA1-45E8-A061-A937DDB55EFDQ35925515-8C0699BD-6E31-4EB7-928D-52EF7111FC62Q36065143-EC598A51-53B0-40AA-98C3-5FFAF128F9D2Q36100579-6187F260-3FA8-41D6-BD11-EFFBBBA67396Q36118876-BB8B2C67-F8C2-4565-9971-1673AA68B6A6Q36514160-571FD12F-7D16-427E-B4BF-EFD850F0D793Q37122541-20B64485-1A6A-44A8-A47D-563E15DC5E76Q37296558-F3DF32BA-B22F-4138-B0E2-40625933153EQ37298808-8AD561BF-DA3E-496D-A6B0-9002AFB69CE8Q37735483-9FB7D054-3465-4D39-9CFC-D4F907E38B65Q37885642-1A58C193-8E70-4C02-8D76-39EAE287CA52Q38970751-D77CB62F-BA57-46E7-8B77-850ACA517C68Q42152583-28252DAA-9C83-454B-A4DB-12482C8058B3Q44403510-9329CF97-D474-4DC0-BA1E-84920034DF90Q54247816-CDD4F2C2-1B23-43D3-A7C9-AEA121D292A9
P2860
Genome-wide association study of prostate cancer mortality
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genome-wide association study of prostate cancer mortality
@ast
Genome-wide association study of prostate cancer mortality
@en
type
label
Genome-wide association study of prostate cancer mortality
@ast
Genome-wide association study of prostate cancer mortality
@en
prefLabel
Genome-wide association study of prostate cancer mortality
@ast
Genome-wide association study of prostate cancer mortality
@en
P2093
P2860
P50
P1476
Genome-wide association study of prostate cancer mortality
@en
P2093
Fredrick R Schumacher
Jennifer A Sinnott
Kathryn L Penney
Matthew L Freedman
Peter L Kraft
Saumyadipta Pyne
P2860
P304
P356
10.1158/1055-9965.EPI-10-0601
P50
P577
2010-10-26T00:00:00Z